Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL’s Galleri<sup>®</sup> Multi-Cancer Early Detection Test to Asia - GRAIL
Summary
Samsung C&T and Samsung Electronics will invest $110 million in GRAIL and collaborate to bring the Galleri multi-cancer early detection test to key Asian markets. Samsung C&T will lead commercialization in South Korea, with possible expansion into Japan and Singapore. The parties plan to use GRAIL as the exclusive MCED partner in South Korea and expect commercial operations to begin after definitive agreements are signed. Samsung Electronics and GRAIL will also explore deeper collaboration around health data integration, AI, and longitudinal clinical research.
Classifications
industries
Entertainment
applications
Web and Content Management
AskAI Classifications
Labels
No AI classifications detected